Related references
Note: Only part of the references are listed.pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells
Mimi M. Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Cleavable PEGylation: a strategy for overcoming the PEG dilemma in efficient drug delivery
Yan Fang et al.
DRUG DELIVERY (2017)
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Manju Kanamala et al.
BIOMATERIALS (2016)
Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells
Hongtao Xu et al.
PHARMACEUTICAL RESEARCH (2016)
High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer
Li Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
New Developments in Liposomal Drug Delivery
Bhushan S. Pattni et al.
CHEMICAL REVIEWS (2015)
Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation
Wenli Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug
Hongtao Xu et al.
PHARMACEUTICAL RESEARCH (2015)
Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery
Jie Tang et al.
JOURNAL OF DRUG TARGETING (2014)
Development of High-Content Gemcitabine PEGylated Liposomes and Their Cytotoxicity on Drug-Resistant Pancreatic Tumour Cells
Hongtao Xu et al.
PHARMACEUTICAL RESEARCH (2014)
Cancer nanomedicines: So many papers and so few drugs!
Vincent J. Venditto et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
Hiroto Hatakeyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Liposome-like nanostructures for drug delivery
Weiwei Gao et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Fusogenic activity of PEGylated pH-sensitive liposomes
Zeljka Vanic et al.
JOURNAL OF LIPOSOME RESEARCH (2012)
Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs
Gina Song et al.
JOURNAL OF LIPOSOME RESEARCH (2012)
Near-infrared light-sensitive micelles for enhanced intracellular drug delivery
Gong-Yan Liu et al.
JOURNAL OF MATERIALS CHEMISTRY (2012)
Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon
Daquan Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
pH-Sensitive mPEG-Hz-Cholesterol Conjugates as a Liposome Delivery System
Daquan Chen et al.
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS (2010)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
Effect of the Lipid Chain Melting Transition on the Stability of DSPE-PEG (2000) Micelles
Mark Kastantin et al.
LANGMUIR (2009)
Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
Roland Andersson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Gemcitabine resistance in pancreatic cancer: Picking the key players
Michael P. Kim et al.
CLINICAL CANCER RESEARCH (2008)
Sheddable coatings for long-circulating nanoparticles
Birgit Romberg et al.
PHARMACEUTICAL RESEARCH (2008)
Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: The effect of substitutes at the hydrazone linkage on the pH stability of PEG-PE conjugates
Amit A. Kale et al.
BIOCONJUGATE CHEMISTRY (2007)
Pegylation of liposomes favours the endosornal degradation of the delivered phosphodiester oligonucleotides
K. Remaut et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
H. Hatakeyama et al.
GENE THERAPY (2007)
Phase behaviour of polymer-grafted DPPC membranes for drug delivery systems design
M Pappalardo et al.
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY (2005)
Liposomes, disks, and spherical micelles: Aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids
M Johnsson et al.
BIOPHYSICAL JOURNAL (2003)
Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models
A Gabizon et al.
JOURNAL OF DRUG TARGETING (2002)
Amphiphilic poly-N-vinylpyrrolidones:: synthesis, properties and liposome surface modification
VP Torchilin et al.
BIOMATERIALS (2001)
Area per lipid and acyl length distributions in fluid phosphatidylcholines determined by 2H NMR spectroscopy
HI Petrache et al.
BIOPHYSICAL JOURNAL (2000)
Share Paper
